z-logo
open-access-imgOpen Access
Analysis of major histocompatibility complex class I folding: novel insights into intermediate forms
Author(s) -
Simone L. C.,
Tuli A.,
Simone P. D.,
Wang X.,
Solheim J. C.
Publication year - 2012
Publication title -
tissue antigens
Language(s) - English
Resource type - Journals
eISSN - 1399-0039
pISSN - 0001-2815
DOI - 10.1111/j.1399-0039.2012.01849.x
Subject(s) - major histocompatibility complex , mhc class i , mhc restriction , antigen presentation , folding (dsp implementation) , peptide , chemistry , biology , antigen processing , antigen , microbiology and biotechnology , biochemistry , immune system , genetics , t cell , electrical engineering , engineering
Folding around a peptide ligand is integral to the antigen presentation function of major histocompatibility complex (MHC) class I molecules. Several lines of evidence indicate that the broadly cross‐reactive 34‐1‐2 antibody is sensitive to folding of the MHC class I peptide‐binding groove. Here, we show that peptide‐loading complex proteins associated with the murine MHC class I molecule K d are found primarily in association with the 34‐1‐2 + form. This led us to hypothesize that the 34‐1‐2 antibody may recognize intermediately, as well as fully, folded MHC class I molecules. To further characterize the form(s) of MHC class I molecules recognized by 34‐1‐2, we took advantage of its cross‐reactivity with L d . Recognition of the open and folded forms of L d by the 64‐3‐7 and 30‐5‐7 antibodies, respectively, has been extensively characterized, providing us with parameters against which to compare 34‐1‐2 reactivity. We found that the 34‐1‐2 + L d molecules displayed characteristics indicative of incomplete folding, including increased tapasin association, endoplasmic reticulum retention, and instability at the cell surface. Moreover, we show that an L d ‐specific peptide induced folding of the 34‐1‐2 + L d intermediate. Altogether, these results yield novel insights into the nature of MHC class I molecules recognized by the 34‐1‐2 antibody.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here